The legacy of Viagra, and its developer copyright, presents a challenging case study for investors. Originally a blockbuster drug, generating billions in revenue , its intellectual property lapse created a deluge of lower-priced alternatives , significantly impacting its dominance. While specific firms may attempt to capitalize on male sexual dysfu